US Patent Issued to Sumitomo Pharma, NATIONAL CANCER CENTER on July 7 for "Tertiary amide derivatives substituted with 4-membered ring structure" (Japanese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,941, issued on July 7, was assigned to Sumitomo Pharma Co. Ltd. (Osaka, Japan) and NATIONAL CANCER CENTER (Tokyo).

"Tertiary amide derivatives substituted with 4-membered ring structure" was invented by Shunichiro Uesugi (Osaka, Japan), Yusuke Kamei (Osaka, Japan), Hitoshi Ban (Osaka, Japan), Seiji Kamioka (Osaka, Japan), Yusuke Imazaki (Osaka, Japan), Hideaki Ogiwara (Tokyo) and Mariko Sasaki (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "[Problem] The present disclosure provides tertiary amide derivatives substituted with a 4-membered ring structure that are useful as medicines and pharmaceutically acceptable salts thereof, pharmaceutical co...